(Q73318562)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

R A Heijtink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P van Bergen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W P Paulij

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R A de Man

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A D Osterhaus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1531-1538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Yeast recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Hepatitis B surface antigen (HBsAg) subtype-specific antibodies in persons vaccinated against hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Clinical evaluation of a recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Quantitation of hepatitis B surface antibody by an automated microparticle enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Second generation assays for the detection of antibody to HBsAg using recombinant DNA-derived HBsAg

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

HBV-DNA detection by gene amplification in acute hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Low response to hepatitis B virus vaccine in Costa Rican health-care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Persistence of specific antibodies after hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

Efficacy of hepatitis B vaccination: knowledge among clinical medical students

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900433-8

7 January 2021

10.1016/S0264-410X(99)00433-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618551%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference